Bodily Distress Syndrome
7
0
3
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (7)
Reducing Fear of Cancer Recurrence in Danish Colorectal Cancer Survivors
Central Processing of Odour Stimuli in Patients With Functional Somatic Disorder, MCS or Post Covid Compared to Healthy Controls
DISTRESS Trial Functional Disorders - the DISTRESS Trial
Psychiatric Disorders and Functional Somatic Disorders
Health Care Use and Costs of Functional Somatic Disorders
Welfare Benefits in Functional Somatic Disorders
Psychological Risk Factors for Functional Somatic Disorders